BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, June 18, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Other news to note for March 24, 2026

March 24, 2026
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Belief, Biocare, Biocytogen, Biogen, BMS, Bio-Thera, Boehringer, CDR-Life, Coagusense, Corxel, Doasense, Eisai, Everest, Eyepoint, Grand, Glyconex, Immunitybio, Intas, Insitro, Mindwave, Moonlight, Nippon Kayaku, Novartis, Ocular, Proteintech.
Read More

In the clinic for March 24, 2026

March 24, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: Anavex, Apogee, Bausch + Lomb, Dizal, Epicapture, Harbour, Immunexpress, Insmed, Nanoscope, Nykode, Oryon, Pfizer, Sensorion, Sydnexis, Valneva.
Read More

Financings for March 24, 2026

March 24, 2026
Biopharma and med-tech companies raising money in public or private financings, including: Alligator, Diamyd, Hyperfine, Renovorx, Tempest.
Read More

Appointments and advancements for March 24, 2026

March 24, 2026
New hires and promotions in the biopharma and med-tech industries, including: Anaveon, Aurinia, Biostem, Cardinal, Damora, Palvella, Persica.
Read More

Regulatory actions for March 24, 2026

March 24, 2026
Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Argo, Belief, Fujirebio, Gyre, H.U. Groupe, Peijia Medical, Sun, Telix.
Read More

Other news to note for March 24, 2026

March 24, 2026
Biopharma and med-tech happenings in Asia-Pacific, including deals and partnerships, and other news in brief: A.D.A.M. Innovations, Cipla, Co-Diagnostics, Cosara Diagnostics, Daiichi Sankyo, Egret, Fennec, Genexine, Hamamatsu Photonics, HCW Biologic, Leveragen, Oxford Nanopore Technologies, PRG S&T, Sakura Finetek, Samsung Bioepis, Sandoz, Sentynl, Trimmune, Voro, Zydus.
Read More

In the clinic for March 24, 2026

March 24, 2026
Clinical updates for biopharma and med tech in Asia-Pacific, including data readouts and publications: Endogenex, Kelun-Biotech, Qiagen.
Read More

Appointments and advancements for March 24, 2026

March 24, 2026
New hires and promotions in the biopharma and med-tech industries in Asia-Pacific, including: Harbour Biomed.
Read More

Regulatory actions for March 23, 2026

March 23, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Eledon, Intrabio, Novo Nordisk, Rhythm, Siemens.
Read More

Other news to note for March 23, 2026

March 23, 2026
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Caris, Co-Diagnostics, Cosara, Ferring, Hamamatsu, Ibex, Sakura.
Read More
Previous 1 2 … 36 37 38 39 40 41 42 43 44 … 1810 1811 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 17, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 16, 2026
  • Red blood cells, DNA

    For clonal hematopoiesis, epigenetics can be in driver’s seat

    BioWorld Science
    Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
  • Illustration of amyloid plaques in Alzheimer's disease

    Elixiron’s enrupatinib shows upbeat interim phase II AD results

    BioWorld
    Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
  • Brain with puzzle piece removed

    Gene replacement rescues autism-related phenotypes in mice

    BioWorld Science
    Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing